Firy Inc. vs Medpace Holdings Inc — how do they compare? Firy Inc. trades at $8.52 (market cap $125.48M), while Medpace Holdings Inc trades at $533.78 (market cap $15.11B). The key difference: Medpace Holdings Inc is far larger — about 120.4× Firy Inc.'s market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Firy Inc. nearer its low. Which is the better fit depends on your goals.
| FIRY | MEDP | |
|---|---|---|
Market Cap | $125.48M | $15.11B |
Sector | Consumer Cyclical | Technology |
52-Week High | $12.45 | $620.59 |
52-Week Low | $2.28 | $308.88 |
Enterprise Value | $69.16M | $14.58B |
Signals from Pluang's Aura AI — not financial advice
FIRY (formerly Skillz Inc.) trades at $8.04, down 4.74% today, amid mixed technical signals with a bullish overall trend but neutral oscillators. The company recently rebranded and reported Q1 2026 results showing revenue growth to $104.5M but persistent losses with a net margin of -57.48%. Cash flow remains negative at -$86.41M for 2025, though operating losses have narrowed from 2022 peaks.
Outlook is cautious; while technicals suggest near-term support at $8, fundamental challenges include deep losses and negative cash flow. Analyst sentiment is mixed with 60% hold ratings. Key risks are profitability timeline and competitive pressure, but rebranding and legal victories may support long-term turnaround if execution improves.
No Aura AI signal available yet.
Trailing returns across standard periods
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →